Stoke Therapeutics Correlations
| STOK Stock | USD 8.29 0.14 1.72% |
The current 90-days correlation between Stoke Therapeutics and Adaptimmune Therapeutics Plc is 0.09 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Stoke Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Stoke Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Stoke Therapeutics Correlation With Market
Modest diversification
The correlation between Stoke Therapeutics and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Stoke |
Moving together with Stoke Stock
| 0.63 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.7 | ELVN | Enliven Therapeutics | PairCorr |
| 0.67 | SCLX | Scilex Holding | PairCorr |
| 0.68 | CRNX | Crinetics Pharmaceuticals | PairCorr |
| 0.69 | MSFT | Microsoft Aggressive Push | PairCorr |
Moving against Stoke Stock
| 0.66 | LUCD | Lucid Diagnostics | PairCorr |
| 0.52 | WM | Waste Management | PairCorr |
| 0.35 | GE | GE Aerospace | PairCorr |
| 0.7 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
| 0.63 | CVX | Chevron Corp | PairCorr |
| 0.61 | T | ATT Inc Earnings Call Today | PairCorr |
| 0.51 | XOM | Exxon Mobil Corp Aggressive Push | PairCorr |
| 0.48 | INTC | Intel Sell-off Trend | PairCorr |
| 0.43 | CSCO | Cisco Systems | PairCorr |
| 0.4 | MMM | 3M Company | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Stoke Stock performing well and Stoke Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Stoke Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ADAP | 3.10 | (0.80) | 0.00 | (1.08) | 0.00 | 4.84 | 52.59 | |||
| FIXX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| BDTX | 3.94 | (0.29) | 0.00 | (0.21) | 0.00 | 7.09 | 29.04 | |||
| HARP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| RLAY | 4.18 | (0.40) | 0.00 | (0.27) | 0.00 | 6.27 | 26.72 | |||
| PLRX | 6.35 | (1.80) | 0.00 | (0.61) | 0.00 | 10.39 | 80.84 | |||
| ARVN | 3.70 | (0.66) | 0.00 | (0.33) | 0.00 | 5.93 | 61.27 | |||
| PASG | 4.19 | (0.30) | 0.00 | (0.29) | 0.00 | 7.69 | 56.48 | |||
| BCEL | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TCRR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Stoke Therapeutics Corporate Management
| CPA CPA | Chief Officer | Profile | |
| Jonathan JD | Corporate Counsel | Profile | |
| Shamim MS | Senior Officer | Profile | |
| Dawn Kalmar | Chief Officer | Profile | |
| Eric Olson | Chief Officer | Profile | |
| FACC MD | Chief Officer | Profile | |
| Joan Wood | Chief Officer | Profile |